XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in-Capital
Accumulated Other Comprehensive Income
Treasury Stock
Accumulated Deficit
Total
Balance at Dec. 31, 2017 $ 2,291 $ 1,250,899 $ 2,194 $ (3,102) $ (1,182,053) $ 70,229
Balance (in shares) at Dec. 31, 2017 229,073,517     587,151    
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company         (85,608) (85,608)
Other comprehensive (loss) gain     (610)     (610)
Stock-based compensation $ 8 8,763       8,771
Stock-based compensation (in shares) 741,216          
Stock dividend   52     (52)  
Stock dividend (in shares) 29,762          
Public offerings, common stock, net $ 38 6,978       7,016
Public offerings, common stock, net (in shares) 3,804,654          
Stock option exercises $ 5 168   $ (35)   138
Stock option exercises (in shares) 511,412     17,606    
Equity component of 3.75% Convertible Senior Notes issued, net of issuance costs and income tax expense   28,586       28,586
Purchase of capped calls   (16,000)       (16,000)
Purchase of common stock forward       $ (27,500)   (27,500)
Purchase of common stock forward (in shares)       14,397,906    
Exercise of warrants (in shares) 100          
Provision for common stock warrants   10,190       10,190
Balance (Cumulative effect from adoption of ASC 842) at Dec. 31, 2018         1,200 1,200
Balance at Dec. 31, 2018 $ 2,342 1,289,636 1,584 $ (30,637) (1,266,513) (3,588)
Balance (in shares) at Dec. 31, 2018 234,160,661     15,002,663    
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           (30,547)
Balance at Mar. 31, 2019 $ 2,445 1,316,815 1,374 $ (30,637) (1,297,072) $ (7,075)
Balance (in shares) at Mar. 31, 2019 244,537,235     15,002,663   244,537,235
Balance (Cumulative effect from adoption of ASC 842) at Dec. 31, 2018         1,200 $ 1,200
Balance at Dec. 31, 2018 $ 2,342 1,289,636 1,584 $ (30,637) (1,266,513) (3,588)
Balance (in shares) at Dec. 31, 2018 234,160,661     15,002,663    
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           (47,885)
Balance at Jun. 30, 2019 $ 2,470 1,325,381 1,460 $ (30,681) (1,314,425) $ (15,795)
Balance (in shares) at Jun. 30, 2019 246,975,173     15,020,437   246,975,173
Balance (Cumulative effect from adoption of ASC 842) at Dec. 31, 2018         1,200 $ 1,200
Balance at Dec. 31, 2018 $ 2,342 1,289,636 1,584 $ (30,637) (1,266,513) (3,588)
Balance (in shares) at Dec. 31, 2018 234,160,661     15,002,663    
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           (65,707)
Balance at Sep. 30, 2019 $ 2,540 1,340,781 929 $ (31,216) (1,332,259) $ (19,225)
Balance (in shares) at Sep. 30, 2019 253,982,578     15,259,045   253,982,578
Balance (Cumulative effect from adoption of ASC 842) at Dec. 31, 2018         1,200 $ 1,200
Balance at Dec. 31, 2018 $ 2,342 1,289,636 1,584 $ (30,637) (1,266,513) (3,588)
Balance (in shares) at Dec. 31, 2018 234,160,661     15,002,663    
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company         (83,743) (83,743)
Other comprehensive (loss) gain     (296)     (296)
Stock-based compensation $ 19 10,871       10,890
Stock-based compensation (in shares) 1,876,503          
Stock dividend   52     (52)  
Stock dividend (in shares) 19,286          
Public offerings, common stock, net $ 622 157,722       158,344
Public offerings, common stock, net (in shares) 62,333,585          
Stock option exercises $ 12 1,784   $ (579)   1,217
Stock option exercises (in shares) 1,151,307     256,382    
Exercise of warrants $ 53 14,099       14,152
Exercise of warrants (in shares) 5,250,750          
Provision for common stock warrants   6,513       6,513
Accretion of discount, preferred stock   (1,978)       (1,978)
Conversion of preferred stock $ 138 28,254       28,392
Conversion of preferred stock (in shares) 13,845,468          
Balance at Dec. 31, 2019 $ 3,186 1,506,953 1,288 $ (31,216) (1,350,307) $ 129,904
Balance (in shares) at Dec. 31, 2019 318,637,560     15,259,045   318,637,560
Balance at Mar. 31, 2019 $ 2,445 1,316,815 1,374 $ (30,637) (1,297,072) $ (7,075)
Balance (in shares) at Mar. 31, 2019 244,537,235     15,002,663   244,537,235
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (17,338)
Balance at Jun. 30, 2019 $ 2,470 1,325,381 1,460 $ (30,681) (1,314,425) $ (15,795)
Balance (in shares) at Jun. 30, 2019 246,975,173     15,020,437   246,975,173
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (17,822)
Balance at Sep. 30, 2019 $ 2,540 1,340,781 929 $ (31,216) (1,332,259) $ (19,225)
Balance (in shares) at Sep. 30, 2019 253,982,578     15,259,045   253,982,578
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (18,036)
Balance at Dec. 31, 2019 $ 3,186 1,506,953 1,288 $ (31,216) (1,350,307) $ 129,904
Balance (in shares) at Dec. 31, 2019 318,637,560     15,259,045   318,637,560
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (37,432)
Balance at Mar. 31, 2020 $ 3,222 1,519,094 1,052 $ (31,224) (1,387,752) $ 104,392
Balance (in shares) at Mar. 31, 2020 322,220,469     15,261,007   322,220,469
Balance at Dec. 31, 2019 $ 3,186 1,506,953 1,288 $ (31,216) (1,350,307) $ 129,904
Balance (in shares) at Dec. 31, 2019 318,637,560     15,259,045   318,637,560
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (46,833)
Balance at Jun. 30, 2020 $ 3,482 1,658,438 1,159 $ (31,359) (1,397,160) $ 234,560
Balance (in shares) at Jun. 30, 2020 348,201,792     15,292,591   348,201,792
Balance at Dec. 31, 2019 $ 3,186 1,506,953 1,288 $ (31,216) (1,350,307) $ 129,904
Balance (in shares) at Dec. 31, 2019 318,637,560     15,259,045   318,637,560
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (112,050)
Balance at Sep. 30, 2020 $ 4,061 2,083,169 1,846 $ (40,434) (1,462,377) $ 586,265
Balance (in shares) at Sep. 30, 2020 406,123,816     15,926,068   406,123,816
Balance at Dec. 31, 2019 $ 3,186 1,506,953 1,288 $ (31,216) (1,350,307) $ 129,904
Balance (in shares) at Dec. 31, 2019 318,637,560     15,259,045   318,637,560
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company         (596,155) $ (596,155)
Other comprehensive (loss) gain     1,163     1,163
Stock-based compensation $ 4 17,131       17,135
Stock-based compensation (in shares) 439,649          
Stock dividend   26     (26)  
Stock dividend (in shares) 5,156          
Public offerings, common stock, net $ 790 1,270,872       $ 1,271,662
Public offerings, common stock, net (in shares) 78,976,250         79,000,000.0
Stock option exercises $ 181 41,060   $ (9,218)   $ 32,023
Stock option exercises (in shares) 18,056,200     667,023    
Equity component of 3.75% Convertible Senior Notes issued, net of issuance costs and income tax expense   100,761       100,761
Purchase of capped calls   (16,253)       (16,253)
Termination of capped calls   24,158       24,158
Exercise of warrants $ 52 (52)        
Exercise of warrants (in shares) 5,180,457          
Provision for common stock warrants   439,915       439,915
Accretion of discount, preferred stock   (29)       (29)
Conversion of preferred stock $ 30 1,149       1,179
Conversion of preferred stock (in shares) 2,998,526          
Conversion of 5.5% and 7.5% Convertible Senior Notes $ 306 62,247       62,553
Conversion of 5.5% and 7.5% Convertible Senior Notes (in shares) 30,615,615          
Repurchase of 5.5% Convertible Senior Notes, net of income tax benefit $ 94 (50,864)       (50,770)
Repurchase of 5.5% Convertible Senior Notes, net of income tax benefit (in shares) 9,409,591          
Shares issued for acquisitions $ 97 49,576       49,673
Shares issued for acquisitions (in shares) 9,658,465          
Balance at Dec. 31, 2020 $ 4,740 3,446,650 2,451 $ (40,434) (1,946,488) $ 1,466,919
Balance (in shares) at Dec. 31, 2020 473,977,469     15,926,068   473,977,469
Balance at Mar. 31, 2020 $ 3,222 1,519,094 1,052 $ (31,224) (1,387,752) $ 104,392
Balance (in shares) at Mar. 31, 2020 322,220,469     15,261,007   322,220,469
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (9,401)
Balance at Jun. 30, 2020 $ 3,482 1,658,438 1,159 $ (31,359) (1,397,160) $ 234,560
Balance (in shares) at Jun. 30, 2020 348,201,792     15,292,591   348,201,792
Increase (Decrease) in Stockholders' Equity            
Net loss attributable to the Company           $ (65,217)
Balance at Sep. 30, 2020 $ 4,061 2,083,169 1,846 $ (40,434) (1,462,377) $ 586,265
Balance (in shares) at Sep. 30, 2020 406,123,816     15,926,068   406,123,816
Increase (Decrease) in Stockholders' Equity            
Public offerings, common stock, net (in shares)           4,400,000
Balance at Dec. 31, 2020 $ 4,740 $ 3,446,650 $ 2,451 $ (40,434) $ (1,946,488) $ 1,466,919
Balance (in shares) at Dec. 31, 2020 473,977,469     15,926,068   473,977,469